| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Access Physicians is a physician-founded, multispecialty group that is improving outcomes by increasing access to exceptional care through telemedicine.
Altos Solutions is a Los Altos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Irvine Pharmaceuticals is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Freestone Medical Center is a medical center located in Fairfield, TX that provides high quality treatment and care from highly skilled and compassionate physicians, nurses and support staff.